Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Less pain, more mobility, and a noticeable improvement in how your body feels and performs
5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT) an enzyme linked to metabolic rate regulation, fat storage, and cellular energy balance
It binds G-actin monomers with high affinity, sequestering monomeric actin and controlling its availability for polymerization
Certain medical conditions increase the risk of B12 deficiency, including Crohn's disease, coeliac disease, and other malabsorption disorders